Tumor lysate-pulsed DC vaccine (Jonsson Comprehensive Cancer Center)

N/A

Report date: 2024/04/12 17:56:04

Base Information

Drug NameTumor lysate-pulsed DC vaccine (Jonsson Comprehensive Cancer Center)
Drug Alias NameAutologous tumor lysate-pulsed dendritic cell vaccine (Jonsson Comprehensive Cancer Center)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGlioblastomaAstrocytomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUclas Jonsson Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesUclas Jonsson Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsGlioblastomaAstrocytomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A